Skip to main content
Materials Today Bio logoLink to Materials Today Bio
. 2026 Mar 18;37:103024. doi: 10.1016/j.mtbio.2026.103024

Corrigendum to ‘CD11b-modified ROS/pH-responsive nanoparticles co-deliver Dioscin and siRNA to improve cardiac repair after myocardial infarction by reducing neutrophil recruitment’ [Mater. Today Bio 34, October 2025, 102226]

Nannan Xu a,1, Zuofei Chi b,1, He Zhang c, Jiake Wu c, Ruowen Sun b,⁎, Chunyang Tian c,⁎⁎
PMCID: PMC13037548  PMID: 41923983

The authors regret < The ultrasound images for the sham and MI groups in Fig. 7A were duplicated. We sincerely apologize for this oversight and wish to revise the figure accordingly. This revision replaces the ultrasound image of the MI group in Fig. 7A. The corrected Fig. 7 is attached as an email attachment. Additionally, we have thoroughly rechecked the manuscript to prevent similar errors from recurring.

We confirmed that this correction will not change the main discussion and conclusions of the work.

Image 1

Fig. 7. In vivo assessment of Dio/siICAM-1@MSN@PDA-CD11b′s effects on injured myocardial tissue and cardiac function in MI mice. (A) Echocardiogram demonstrating the waveform characteristics of heart in each group of mice. (B) Differences in LVEF and LVFS between each group of mice. (C–D) Masson's trichrome staining (C, scale bar: 20 μm) and TUNEL (D, scale bar: 50 μm) depicting the differences in myocardial infarct area and the number of apoptotic cardiomyocytes in each group of mice, respectively. *P < 0.05, **P < 0.01. N = 3 for each experiment.

The authors would like to apologize for any inconvenience caused.

Contributor Information

Ruowen Sun, Email: sunrw@sj-hospital.org.

Chunyang Tian, Email: tianchunyang@sj-hospital.org.


Articles from Materials Today Bio are provided here courtesy of Elsevier

RESOURCES